前CEO锒铛入狱，10x Genomics临床雄心，制药业押注人工智能——基因工程与生物技术新闻
Ex-CEO Behind Bars, 10x’s Clinical Ambitions, Pharma’s AI Gambit - Genetic Engineering and Biotechnology News
生命科学资讯
生物技术与制药领域的最新动态
通过分层交叉熵损失改进图谱规模单细胞注释模型 - 《自然》
Improving atlas-scale single-cell annotation models with hierarchical cross-entropy loss - Nature
2026年值得买入的4只最佳基因测序股 - The Motley Fool
4 Best Genetic Sequencing Stocks To Buy in 2026 - The Motley Fool
剖析10x Genomics：13位分析师分享观点 - Benzinga
Breaking Down 10x Genomics: 13 Analysts Share Their Views - Benzinga
胶囊技术拓展单细胞实验可能性 - GenomeWeb
Capsule Techs Expand Possibilities for Experiments on Single Cells - GenomeWeb
Leerink Partners因定价担忧下调10X Genomics股票目标价 - Investing.com
Leerink Partners lowers 10X Genomics stock price target on pricing concerns - Investing.com
Leerink Partners因定价担忧下调10X Genomics股价目标 - Investing.com
Leerink Partners lowers 10X Genomics stock price target on pricing concerns - Investing.com
单细胞基因组测序市场即将迎来繁荣 |• 10x Genomics • Illumina - openPR.com
Single-Cell Genome Sequencing Market Is Going to Boom |• 10x Genomics • Illumina - openPR.com
新合作与超预期收入后，审视10x Genomics（TXG）的估值
A Look At 10x Genomics (TXG) Valuation After New Collaborations And Revenue Above Guidance - simplywall.st
审视10x Genomics（TXG）在新合作及超预期营收后的估值状况——Simplywall.st
A Look At 10x Genomics (TXG) Valuation After New Collaborations And Revenue Above Guidance - simplywall.st
10x Genomics公司（纳斯达克：TXG）股价飙升34%，投资者悲观情绪低于预期 - simplywall.st
10x Genomics, Inc. (NASDAQ:TXG) Stock Rockets 34% As Investors Are Less Pessimistic Than Expected - simplywall.st
10x Genomics公司（纳斯达克：TXG）股价飙升34%，投资者悲观情绪低于预期 - simplywall.st
10x Genomics, Inc. (NASDAQ:TXG) Stock Rockets 34% As Investors Are Less Pessimistic Than Expected - simplywall.st
评估10x Genomics（TXG）近期股价上涨后的估值 - 雅虎财经
Assessing 10x Genomics (TXG) Valuation After Recent Share Price Momentum - Yahoo Finance
J. Craig Venter 推出旨在提升诊断洞察力的基因组学初创公司 - Fierce Biotech
J. Craig Venter launches genomics startup designed to boost diagnostic insights - Fierce Biotech
10x Genomics将于2026年2月12日公布2025年第四季度及全年财务业绩 - BioSpace
10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 - BioSpace
10x Genomics临床野心扩张，势头超越分析师预期 - simplywall.st
10x Genomics Expands Clinical Ambitions As Momentum Outruns Analyst Targets - simplywall.st
10x Genomics将于2026年2月12日公布2025年第四季度及全年财务业绩 - 纳斯达克
10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 - Nasdaq
10x Genomics将于2026年2月12日公布2025年第四季度及全年财务业绩 - Stock Titan
10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 - Stock Titan
10x Genomics将于2026年2月12日公布2025年第四季度及全年财务业绩 - 雅虎财经
10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 - Yahoo Finance
Zacks行业展望聚焦Doximity、10x Genomics与Omnicell——雅虎财经报道
Zacks Industry Outlook Highlights Doximity, 10x Genomics and Omnicell - Yahoo Finance